Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 2.85 % |
3 Month Return | -6.28 % |
1 Year Return | -15.23 % |
Market Stats | |
Previous Close | ₹318.00 |
Open | ₹315.10 |
Volume | 34.44K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹691.65Cr |
P/E Ratio | 55.69 |
PEG Ratio | -34.17 |
Market Cap | ₹691.65 Cr |
P/B Ratio | 3.11 |
EPS | 5.37 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 5.36 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹691.65 Cr | 92.77% | 0.62 | ₹11 Cr | ₹153 Cr | |
NA | ₹326.45 Cr | 172.27% | 1.27 | NA | NA | |
NA | ₹5,843.25 Cr | 468.1% | 0.50 | ₹33 Cr | ₹204 Cr | |
NA | ₹159.73 Cr | 173.38% | 2.00 | ₹14 Cr | ₹502 Cr | |
BUY | ₹12,698.69 Cr | 7.69% | 0.51 | NA | NA |
Organisation | Sakar Healthcare Ltd |
Headquarters | Ahmedabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Sakar Healthcare Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, 2.41 Cr → 4.8 Cr (in ₹), with an average increase of 49.8% per quarter
Retail Holding Up
Retail Investor have increased holdings from 22.71% to 22.80% in Sep 2024 quarter
Revenue Rich
Revenue is up for the last 2 quarters, 41.61 Cr → 43.15 Cr (in ₹), with an average increase of 3.6% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 62.8% return, outperforming this stock by 78.0%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 53.15% of holdings in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 136.8% return, outperforming this stock by 17.7%
FII Holding Down
Foreign Institutions have decreased holdings from 13.52% to 13.42% in Sep 2024 quarter
Price Dip
In the last 1 year, SAKAR stock has moved down by -15.2%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 53.15% | 0.00 | |
Foreign Institutions | 13.42% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 22.8% | 0.42 | |
Others | 10.62% | 0.00 |
Sakar Healthcare Ltd in the last 5 years
Lowest (13.06x)
May 12, 2022
Today (55.69x)
December 12, 2024
Industry (56.92x)
December 12, 2024
Highest (71.76x)
January 24, 2024
Sakar Healthcare Ltd’s net profit jumped 31.87% since last year same period to ₹4.80Cr in the Q2 2024-2025. On a quarterly growth basis, Sakar Healthcare Ltd has generated 99.17% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Sakar Healthcare Ltd is currently in a Bullish trading position according to technical analysis indicators.
Sakar Healthcare Ltd (SAKAR) share price today is ₹319.15
Sakar Healthcare Ltd is listed on NSE
Sakar Healthcare Ltd is not listed on BSE
PE Ratio of Sakar Healthcare Ltd is 55.69
PE ratio = Sakar Healthcare Ltd Market price per share / Sakar Healthcare Ltd Earnings per share
Today’s traded volume of Sakar Healthcare Ltd(SAKAR) is 34.44K.
Today’s market capitalisation of Sakar Healthcare Ltd(SAKAR) is ₹691.65Cr.
Sakar Healthcare Ltd(SAKAR | Price |
---|---|
52 Week High | ₹479 |
52 Week Low | ₹279.85 |
Sakar Healthcare Ltd(SAKAR) share price is ₹319.15. It is down -33.37% from its 52 Week High price of ₹479
Sakar Healthcare Ltd(SAKAR) share price is ₹319.15. It is up 14.04% from its 52 Week Low price of ₹279.85
Sakar Healthcare Ltd(SAKAR | Returns |
---|---|
1 Day Returns | 1.15% |
1 Month Returns | 2.85% |
3 Month Returns | -6.28% |
1 Year Returns | -15.23% |